JM Financial has maintained its Buy rating on Metropolis Healthcare (MHL) with a 12-month target price of Rs 734, implying an upside of 27.2% from the current market price of Rs 577.
The rating and target remain unchanged from the brokerage's previous estimate, following an analyst meeting on August 27.